NIMG-72. CEREBRAL BLOW FLOW AND SUV TRENDS IN PET/MRI FOLLOWING BEVACIZUMAB ADMINISTRATION IN GLIOBLASTOMA

BACKGROUND: Bevacizumab (BEV) is an antibody directed at vascular endothelial growth factor (VEGF) and holds FDA approval in recurrent glioblastoma (GBM). Pseudoprogression with necrosis is a common clinical concern in GBM, and BEV is useful in treating both tumor and necrosis. Though conventionally...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Corbin, Zachary A, Zaharchuk, Greg, Spielman, Daniel M, Recht, Lawrence D
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693070/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.644
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker